These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10555391)

  • 1. The pharmacological management of cognitive dysfunction in Alzheimer's disease.
    Vandewoude MF
    Acta Clin Belg; 1999 Oct; 54(5):306-11. PubMed ID: 10555391
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.
    Paterson RW; Abdi Z; Haines A; Schott JM
    Clin Neurol Neurosurg; 2016 May; 144():64-6. PubMed ID: 26989943
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.
    Senin U; Cherubini A; Palumbo B; Mecocci P
    Funct Neurol; 1997; 12(3-4):211-2. PubMed ID: 9218980
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacotheraphy for Alzheimer's disease.
    Knopman D
    Curr Neurol Neurosci Rep; 2001 Sep; 1(5):428-34. PubMed ID: 11898553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of Alzheimer's disease].
    Ankri J
    Rev Neurol (Paris); 2003 Sep; 159(8-9):819-24. PubMed ID: 13679729
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of cholinesterase inhibitors in Alzheimer disease].
    Sampalmieri M; Troiani MP; Servi M
    Clin Ter; 1993 Dec; 143(6):549-52. PubMed ID: 8306579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treating cognitive disorders in Alzheimer's disease: yes, but not only that].
    Forette F
    Presse Med; 2003 Jul; 32(24 Suppl):S3-4. PubMed ID: 12947600
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic foundations of Alzheimer's disease therapy.
    Giacobini E
    J Physiol Paris; 1998; 92(3-4):283-7. PubMed ID: 9789824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current and future medical treatment of Alzheimer's disease].
    Lemper JC
    Rev Med Brux; 2005 Sep; 26(4):S294-9. PubMed ID: 16240877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's drugs deliver fringe benefits. Cholinesterase inhibitors improve more than just memory.
    Auerbach SH
    Health News; 2003 Mar; 9(3):1-2. PubMed ID: 12703432
    [No Abstract]   [Full Text] [Related]  

  • 13. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.
    Simpkins JW; Singh M; Bishop J
    Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453
    [No Abstract]   [Full Text] [Related]  

  • 15. A neurotrophic rationale for the therapy of neurodegenerative disorders.
    Saragovi HU; Hamel E; Di Polo A
    Curr Alzheimer Res; 2009 Oct; 6(5):419-23. PubMed ID: 19874265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of cognitive dysfunction in dementia disorders.
    Nordberg A
    Acta Neurol Scand Suppl; 1996; 168():87-92. PubMed ID: 8997426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors, neuropsychiatric symptoms, and Alzheimer's disease subtypes: an alternate hypothesis to global cognitive enhancement.
    Brousseau G; Rourke BP; Burke B
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):546-54. PubMed ID: 18179307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not?
    Ames D; Kaduszkiewicz H; van den Bussche H; Zimmermann T; Birks J; Ashby D
    Int Psychogeriatr; 2008 Apr; 20(2):259-92. PubMed ID: 18252031
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological therapy of Alzheimer's disease].
    Claus JJ; Hofman A; Jolles J
    Ned Tijdschr Geneeskd; 1992 Dec; 136(50):2463-6. PubMed ID: 1465168
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination therapy for early Alzheimer's disease: what are we waiting for?
    Doraiswamy PM; Steffens DC
    J Am Geriatr Soc; 1998 Oct; 46(10):1322-4. PubMed ID: 9777922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.